Literature DB >> 23023056

Pushing the reset button: chemical-induced conversion of amniotic fluid stem cells into a pluripotent state.

Sebastian Diecke1, Joseph C Wu.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 23023056      PMCID： PMC3464646          DOI： 10.1038/mt.2012.192

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  22 in total

1.  Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors.

Authors:  Wenlin Li; Wei Wei; Saiyong Zhu; Jinliang Zhu; Yan Shi; Tongxiang Lin; Ergeng Hao; Alberto Hayek; Hongkui Deng; Sheng Ding
Journal:  Cell Stem Cell       Date:  2008-12-18       Impact factor: 24.633

2.  Amniotic fluid cells are more efficiently reprogrammed to pluripotency than adult cells.

Authors:  Elisa Galende; Ioannis Karakikes; Lisa Edelmann; Robert J Desnick; Thomas Kerenyi; Georges Khoueiry; James Lafferty; Joseph T McGinn; Michael Brodman; Valentin Fuster; Roger J Hajjar; Katalin Polgar
Journal:  Cell Reprogram       Date:  2010-04       Impact factor: 1.987

3.  The seminoma cell line TCam-2 is sensitive to HDAC inhibitor depsipeptide but tolerates various other chemotherapeutic drugs and loss of NANOG expression.

Authors:  Daniel Nettersheim; Ad Gillis; Katharina Biermann; Leendert H J Looijenga; Hubert Schorle
Journal:  Genes Chromosomes Cancer       Date:  2011-08-24       Impact factor: 5.006

4.  Induced pluripotent stem cells generated without viral integration.

Authors:  Matthias Stadtfeld; Masaki Nagaya; Jochen Utikal; Gordon Weir; Konrad Hochedlinger
Journal:  Science       Date:  2008-09-25       Impact factor: 47.728

5.  Induction of pluripotent stem cells from fibroblast cultures.

Authors:  Kazutoshi Takahashi; Keisuke Okita; Masato Nakagawa; Shinya Yamanaka
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

6.  Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors.

Authors:  Jeong Beom Kim; Holm Zaehres; Guangming Wu; Luca Gentile; Kinarm Ko; Vittorio Sebastiano; Marcos J Araúzo-Bravo; David Ruau; Dong Wook Han; Martin Zenke; Hans R Schöler
Journal:  Nature       Date:  2008-06-29       Impact factor: 49.962

Review 7.  Induced pluripotent stem cells: current progress and potential for regenerative medicine.

Authors:  Giovanni Amabile; Alexander Meissner
Journal:  Trends Mol Med       Date:  2009-01-21       Impact factor: 11.951

8.  Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.

Authors:  Luigi Warren; Philip D Manos; Tim Ahfeldt; Yuin-Han Loh; Hu Li; Frank Lau; Wataru Ebina; Pankaj K Mandal; Zachary D Smith; Alexander Meissner; George Q Daley; Andrew S Brack; James J Collins; Chad Cowan; Thorsten M Schlaeger; Derrick J Rossi
Journal:  Cell Stem Cell       Date:  2010-09-30       Impact factor: 24.633

9.  Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching.

Authors:  Craig J Taylor; Eleanor M Bolton; Susan Pocock; Linda D Sharples; Roger A Pedersen; J Andrew Bradley
Journal:  Lancet       Date:  2005-12-10       Impact factor: 79.321

10.  Histone deacetylase inhibitors in cell pluripotency, differentiation, and reprogramming.

Authors:  Androniki Kretsovali; Christiana Hadjimichael; Nikolaos Charmpilas
Journal:  Stem Cells Int       Date:  2012-03-08       Impact factor: 5.443
View more
  2 in total

1.  Human Cardiomyocytes Prior to Birth by Integration-Free Reprogramming of Amniotic Fluid Cells.

Authors:  Guihua Jiang; Todd J Herron; Julie Di Bernardo; Kendal A Walker; K Sue O'Shea; Shaun M Kunisaki
Journal:  Stem Cells Transl Med       Date:  2016-07-27       Impact factor: 6.940

2.  Human Amniocytes Are Receptive to Chemically Induced Reprogramming to Pluripotency.

Authors:  Kate E Hawkins; Dafni Moschidou; Danilo Faccenda; Wasco Wruck; Alex Martin-Trujillo; Kwan-Leong Hau; Anna Maria Ranzoni; Veronica Sanchez-Freire; Fabio Tommasini; Simon Eaton; Paolo De Coppi; David Monk; Michelangelo Campanella; Adrian J Thrasher; James Adjaye; Pascale V Guillot
Journal:  Mol Ther       Date:  2017-02-01       Impact factor: 11.454
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.